ADGSOM1 & ADGMIN1  
       
  LAUNCH OF THE 50TH ANNIVERSARY CELEBRATION OF RUKUN NEGARA  
       
  KL SUMMIT 2019  
       
  HAWANA 2018  
       
  AES 2016  
       

 
 
 

May 08, 2024 -Wednesday

 
  MALAYSIA INCREASING IT'S CAPABILITIES IN EARLY PHASE CLINICAL RESEARCH

Wednesday 26/07/2023



Table

Signing of education scholarship agreement, witnessed by Minster of Health & Director of National Pharmaceutical Regulatory Agency


KUALA LUMPUR, July 26 (Bernama) -- Clinical Research Malaysia (CRM) inked an education scholarship agreement with the Ministry of Health (MOH) and National Pharmaceutical Regulatory Agency (NPRA) earlier today at CRM headquarters. Under the agreement, CRM will be sponsoring two NPRA officers to pursue their Master’s program in Clinical Pharmacology at King's College London.

The initiative is aligned with CRM's Phase 1 Realisation Project (P1RP) 2.0, which focuses on further enhancing Malaysia’s capabilities on early phase/first-in-human trials. The project is an extension of the initial P1RP program launched in 2016 in which three NPRA officers and a Medical Oncologist from Sarawak General Hospital were sponsored for postgraduate studies and fellowship attachment respectively, at renowned global institutions, to build their expertise in early phase trials. Investment in human capital development is a continuous effort taken by CRM, an organization wholly-owned by the MOH, to ensure the country’s readiness for safe and high-quality conduct of clinical trials.

Representing the organisations at the signing ceremony were Deputy Secretary-General Finance of MOH, Dato’ Sri Norazman Ayob, Chief Executive Officer of CRM, Dr. Akhmal Yusof as well as NPRA officers Siti Norhayani Ismail and Fatin Diyana Fauzi. The sponsorship agreement was witnessed by YB Dr. Zaliha Mustafa, the Minister of Health and Rosilawati Ahmad, NPRA Director.

During the same program, YB Dr Zaliha also launched the Malaysia Decentralised Clinical Trial (DCT) Guidance Document. This guidance document is a first in Malaysia and will be an important step in aligning to the global trends of clinical trials where patient-centricity becomes more important, as well as adopting new and innovative clinical trial designs. The document was developed by clinical research stakeholders within the country and endorsed by the National Committee for Clinical Research.

About CRM
Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia is a Global Trusted Research Management Organisation guided by principles of HUMANITY, STABILITY & SUSTAINABILITY in providing global clinical trial solutions. CRM enables Speed, Reliability & Quality delivery of Sponsored Clinical Trials through innate understanding of the local clinical research landscape with the international standards of operations. These coupled with fundamental backing of the government ministries provides the organisation an incomparable advantage to work with partners from the nascent stages of development to materialisation of the end product, in order to deliver better treatment and high-skilled job opportunities.

SOURCE: Clinical Research Malaysia (CRM)

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Siti Khadijah Sakaria 
Tel: + 6017 696 3596 | +603-7931 5566 (ext. 119)   
Email: sitikhadijah@clinicalresearch.my 

--BERNAMA

 
 
 

Copyright © 2024 MREM . All rights reserved.